These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9398865)

  • 1. Highly complex chromosomal aberrations in bone marrow of a patient with metastatic prostate neoplasm.
    Azar GM; DiPillo F; Gogineni SK; Godec CJ; Verma RS
    Cancer Genet Cytogenet; 1997 Dec; 99(2):116-20. PubMed ID: 9398865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement].
    Liu W; Lyu R; Huang WY; Li CW; Liu H; Li J; Zou DH; Qiu LG; Yi SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):761-765. PubMed ID: 28641631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic studies of prostatic cancer.
    Lundgren R
    Scand J Urol Nephrol Suppl; 1991; 136():1-35. PubMed ID: 1871551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate.
    Lundgren R; Kristoffersson U; Heim S; Mandahl N; Mitelman F
    Cancer Genet Cytogenet; 1988 Oct; 35(1):103-8. PubMed ID: 3180000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the bones and bone marrow in patients with metastatic carcinoma of the prostate: radiologic, cytologic and cytogenetic findings.
    Spiers AS; Deal DR; Kasimis BS; Miller BR
    J Med; 1982; 13(4):303-7. PubMed ID: 6957529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
    Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I
    Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal clues to the development of prostate tumors.
    Brothman AR; Maxwell TM; Cui J; Deubler DA; Zhu XL
    Prostate; 1999 Mar; 38(4):303-12. PubMed ID: 10075010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic study of four cancers of the prostate.
    Babu VR; Miles BJ; Cerny JC; Weiss L; Van Dyke DL
    Cancer Genet Cytogenet; 1990 Aug; 48(1):83-7. PubMed ID: 2372791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts.
    Williams BJ; Jones E; Kozlowski JM; Vessella R; Brothman AR
    Genes Chromosomes Cancer; 1997 Apr; 18(4):299-304. PubMed ID: 9087570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophagocytosis and complex marrow karyotype in metastatic adenocarcinoma.
    Yu RC; Lau LC
    Blood; 2013 Nov; 122(20):3402. PubMed ID: 24369031
    [No Abstract]   [Full Text] [Related]  

  • 13. Chromosome rearrangements in a metastatic adenocarcinoma of the prostate.
    Gibas Z; Pontes JE; Sandberg AA
    Cancer Genet Cytogenet; 1985 Apr; 16(4):301-4. PubMed ID: 3978598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and pattern of karyotypic abnormalities in human prostate cancer.
    Brothman AR; Peehl DM; Patel AM; McNeal JE
    Cancer Res; 1990 Jun; 50(12):3795-803. PubMed ID: 2340524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic evidence of intratumoral focal heterogeneity in prostatic carcinomas.
    Wullich B; Breitkreuz T; Zwergel T; Unteregger G; Seitz G; Zang KD
    Urol Int; 1992; 48(4):372-7. PubMed ID: 1413297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 16 in primary prostate cancer: a microsatellite analysis.
    Osman I; Scher H; Dalbagni G; Reuter V; Zhang ZF; Cordon-Cardo C
    Int J Cancer; 1997 May; 71(4):580-4. PubMed ID: 9178811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic studies in prostate cancer: are we making progress?
    Brothman AR
    Cancer Genet Cytogenet; 1997 May; 95(1):116-21. PubMed ID: 9140461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic characterization of an established xenografted prostatic adenocarcinoma cell line (PC-82).
    König JJ; Hagemeijer A; Smit B; Kamst E; Romijn JC; Schröder FH
    Cancer Genet Cytogenet; 1988 Aug; 34(1):91-9. PubMed ID: 3395997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic support for primary prostatic cancer in a patient presenting with a soft tissue mass in the leg.
    Molenaar WM; Stoepker ME; de Ruiter AJ; Hoekstra HJ; van den Berg E
    Cancer Genet Cytogenet; 1996 Feb; 86(2):147-9. PubMed ID: 8603342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.